We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LION
526
DELISTED
Fidelity Southern Corporation
LION
$1.28M 0.02%
+49,132
New +$1.16M
AORT icon
527
Artivion
AORT
$1.23B
$1.28M 0.02%
45,000
– –
S
528
DELISTED
Sprint Corporation
S
$1.27M 0.02%
218,600
-11,880
-5% -$73.2K
LW icon
529
Lamb Weston
LW
$6.82B
$1.26M 0.02%
17,201
– –
MGA icon
530
Magna International
MGA
$17.9B
$1.26M 0.02%
27,718
-8,457
-23% -$410K
STAA icon
531
STAAR Surgical
STAA
$1.16B
$1.24M 0.02%
39,000
-11,000
-22% -$429K
NOV icon
532
NOV
NOV
$7.45B
$1.22M 0.02%
47,623
-1,874
-4% -$64.8K
KL
533
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1.22M 0.02%
46,935
+2,738
+6% +$58.1K
IFN
534
Aberdeen India Fund
IFN
$488M
$1.21M 0.02%
60,000
+30,000
+100% +$635K
KGC icon
535
Kinross Gold
KGC
$28.5B
$1.21M 0.02%
376,832
+230,380
+157% +$645K
SJM icon
536
J.M. Smucker
SJM
$12.6B
$1.21M 0.02%
12,987
+609
+5% +$63.6K
AEM icon
537
Agnico Eagle Mines
AEM
$72.6B
$1.21M 0.02%
30,033
+2,066
+7% +$76.1K
EDU icon
538
New Oriental
EDU
$7.84B
$1.21M 0.02%
22,000
+3,000
+16% +$174K
TFCF
539
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$1.19M 0.02%
24,895
– –
ALGN icon
540
Align Technology
ALGN
$12B
$1.18M 0.02%
5,609
+349
+7% +$88.2K
EC icon
541
Ecopetrol
EC
$32.9B
$1.18M 0.02%
74,000
-1,355,000
-95% -$29.1M
DXC icon
542
DXC Technology
DXC
$1.63B
$1.17M 0.02%
22,022
-41,129
-65% -$2.84M
CAH icon
543
Cardinal Health
CAH
$53.4B
$1.17M 0.02%
26,154
-6,718
-20% -$350K
BBD icon
544
Banco Bradesco
BBD
$38.1B
$1.16M 0.02%
187,976
+139,265
+286% +$809K
EXR icon
545
Extra Space Storage
EXR
$31.2B
$1.16M 0.02%
12,864
+8,964
+230% +$815K
ACHN
546
DELISTED
Achillion Pharmaceuticals
ACHN
$1.15M 0.02%
725,000
+75,000
+12% +$212K
GHDX
547
DELISTED
Genomic Health, Inc.
GHDX
$1.14M 0.02%
17,749
+749
+4% +$52.5K
DOC icon
548
Healthpeak Properties
DOC
$15.4B
$1.14M 0.02%
40,900
-5,000
-11% -$138K
SYRS
549
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.14M 0.02%
20,400
– –
HRL icon
550
Hormel Foods
HRL
$13.9B
$1.13M 0.02%
26,528
-499
-2% -$21.5K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.